EPHA4 and proximal spinal muscular atrophy: We hypothesize that this is due to either a too severe clinical phenotype in the SMNΔ7 mouse model with a too short time window for possible re-innervation, or to a limited therapeutic potential of reduced EphA4 in SMA.